Palisade Bio (PALI) Cash from Investing Activities (2010 - 2022)
Palisade Bio (PALI) reported Cash from Investing Activities of -$10000.0 for Q4 2022, up 97.13% on a QoQ basis from -$348000.0 in Q3 2021.
Palisade Bio (PALI) has 12 years of Cash from Investing Activities data on file, last reported at -$10000.0 in Q4 2022.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$10000.0 in Q4 2022, while the trailing twelve-month figure through Sep 2024 was -$10000.0 (changed 0.0% YoY) and the FY2023 annual result came in at -$4000.0, up 60.0% from the prior year.
- Cash from Investing Activities improved to -$10000.0 in Q4 2022 per PALI's latest filing, from -$348000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $5.0 million in Q1 2018 and bottomed at -$348000.0 in Q3 2021.
- The 4-year median for Cash from Investing Activities is -$1357.0 (2018), against an average of $773381.0.
- The widest annual swing landed in 2018, when Cash from Investing Activities sank 320.1%; it then plunged 34900.0% in 2021.
- Tracing PALI's Cash from Investing Activities over 4 years: stood at -$1714.0 in 2018, then soared by 41.66% to -$1000.0 in 2020, then plunged by 34700.0% to -$348000.0 in 2021, then surged by 97.13% to -$10000.0 in 2022.
- Per Business Quant, the three latest PALI Cash from Investing Activities figures stand at -$10000.0 (Q4 2022), -$348000.0 (Q3 2021), and -$1000.0 (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -10,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Sep 30, 2021 | -348,000.00 |
| Sep 30, 2021 | -348,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Dec 31, 2018 | -1,714.00 |
| Dec 31, 2018 | -1,714.00 |
| Mar 31, 2018 | 5.00 Mn |
| Mar 31, 2018 | 5.00 Mn |
| Dec 31, 2017 | -408.00 |
| Dec 31, 2017 | -408.00 |
| Sep 30, 2017 | -190.00 |
| Sep 30, 2017 | -190.00 |
| Dec 31, 2016 | -5.03 Mn |
| Dec 31, 2016 | -5.03 Mn |
| Jun 30, 2016 | -100,926.00 |
| Jun 30, 2016 | -100,926.00 |
| Mar 31, 2016 | 7.49 Mn |
| Mar 31, 2016 | 7.49 Mn |
| Dec 31, 2015 | -2.55 Mn |
| Dec 31, 2015 | -2.55 Mn |
| Sep 30, 2015 | 9.99 Mn |
| Sep 30, 2015 | 9.99 Mn |
| Jun 30, 2015 | -92,924.00 |
| Jun 30, 2015 | -92,924.00 |
| Mar 31, 2015 | -98,276.00 |
| Mar 31, 2015 | -98,276.00 |
| Dec 31, 2014 | -76,041.00 |
| Dec 31, 2014 | -76,041.00 |
| Sep 30, 2014 | -95,092.00 |
| Sep 30, 2014 | -95,092.00 |
| Jun 30, 2014 | -169,538.00 |
| Jun 30, 2014 | -169,538.00 |
| Mar 31, 2014 | -15.22 Mn |
| Mar 31, 2014 | -15.22 Mn |
| Dec 31, 2013 | -92,329.00 |
| Dec 31, 2013 | -92,329.00 |
| Sep 30, 2013 | -207,114.00 |
| Sep 30, 2013 | -207,114.00 |
| Jun 30, 2013 | -140,790.00 |
| Jun 30, 2013 | -140,790.00 |
| Mar 31, 2013 | -96,817.00 |
| Mar 31, 2013 | -96,817.00 |
| Dec 31, 2012 | -66,540.00 |
| Dec 31, 2012 | -66,540.00 |
| Sep 30, 2012 | -38,626.00 |
| Sep 30, 2012 | -38,626.00 |
| Jun 30, 2012 | -120,924.00 |
| Jun 30, 2012 | -120,924.00 |
| Mar 31, 2012 | -28,768.00 |
| Mar 31, 2012 | -28,768.00 |
| Dec 31, 2011 | -60,790.00 |
| Dec 31, 2011 | -60,790.00 |
| Sep 30, 2011 | -132,435.00 |
| Sep 30, 2011 | -132,435.00 |
| Jun 30, 2011 | -192,937.00 |
| Jun 30, 2011 | -192,937.00 |
| Mar 31, 2011 | -94,688.00 |
| Mar 31, 2011 | -94,688.00 |
| Dec 31, 2010 | -125,791.00 |
| Dec 31, 2010 | -125,791.00 |
| Sep 30, 2010 | -88,000.00 |
| Sep 30, 2010 | -88,000.00 |